Immunocore Holdings annual operating margin
2021
2022
2023
2024
2025
Immunocore Holdings Operating Margin Growth & History (IMCR)
Immunocore Holdings's operating margin was −11.34% for fiscal 2025.
View full Immunocore Holdings company overviewImmunocore Holdings annual operating margin history
| Fiscal year | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | −11.34% | +11.38 pp |
| 2024 | 2024-12-31 | −22.71% | +1.20 pp |
| 2023 | 2023-12-31 | −23.91% | +5.74 pp |
| 2022 | 2022-12-31 | −29.66% | +4251.54 pp |
| 2021 | 2021-12-31 | −4,281.19% | — |
Immunocore Holdings quarterly operating margin
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| Q2 2026 | 2026-06-30 | −2.58% | +12.60 pp |
| Q1 2026 | 2026-03-31 | 6.82% | +10.68 pp |
| Q4 2025 | 2025-12-31 | −18.85% | +4.30 pp |
| Q3 2025 | 2025-09-30 | −6.92% | +3.68 pp |
| Q2 2025 | 2025-06-30 | −15.18% | +6.06 pp |
| Q1 2025 | 2025-03-31 | −3.85% | +33.72 pp |
| Q4 2024 | 2024-12-31 | −23.14% | +1.16 pp |
| Q3 2024 | 2024-09-30 | −10.59% | +11.22 pp |
| Q2 2024 | 2024-06-30 | −21.24% | +1.78 pp |
| Q1 2024 | 2024-03-31 | −37.57% | −10.69 pp |
| Q4 2023 | 2023-12-31 | −24.30% | — |
| Q3 2023 | 2023-09-30 | −21.81% | — |
| Q2 2023 | 2023-06-30 | −23.02% | — |
| Q1 2023 | 2023-03-31 | −26.89% | — |
Immunocore Holdings operating margin trends
Across the available reported history, Immunocore Holdings's operating margin increased from −22.71% to −11.34%, a change of +11.38 percentage points. The latest reported quarter, Q2 2026, shows −2.58%.
About the metric
What operating margin means
Operating margin measures the percentage of revenue left after operating costs and expenses. It shows how much operating profit a company generates from each dollar of revenue.
Calculation and source
How operating margin is calculated
TickerStat calculates operating margin as SEC-reported operating income divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Immunocore Holdings filings at SEC.gov ↗